TABLE 2.
Factor | Preliminary model |
Final model |
||
---|---|---|---|---|
Hazard ratio | 95% CI | Adjusted hazard ratio | 95% CI | |
New-generation FQs | 1.91 | 1.14–3.21 | 2.16 | 1.28–3.64 |
Lung diseaseb | 0.51 | 0.28–0.96 | ||
Cancer | 1.60 | 0.81–3.15 | ||
AMG resistance | 1.38 | 0.80–2.39 | ||
Concurrent anti-TB drugs | ||||
Isoniazid | 0.34 | 0.16–0.75 | 0.35 | 0.16–0.78 |
Clofazimine | 2.97 | 1.63–5.43 | 2.51 | 1.37–4.60 |
Linezolid | 1.77 | 0.89–3.51 |
AMG, aminoglycoside; CI, confidence interval; FQs, fluoroquinolones; TB, tuberculosis. Values in boldface indicate P values of <0.05.
Including chronic obstructive pulmonary disease, asthma, and bronchiectasis.